Fosun Pharma USA logo

Creating value through strategic investments in early-stage innovative cutting-edge programs and technologies

Business Models

PRIMARY: Create, Incubate & Expand U.S. Start-ups

  • Interests in innovative preclinical programs
    • Cutting-edge/breakthrough technology platforms
    • Novel biology/pathway/targets
  • Prefer platform and pipeline portfolio opportunities than single assets

  • Open to all stages of preclinical projects but prefer those that already have a lead(s) with 1-3 years before entering clinic

ALTERNATIVE: License-in & JV

  • Single asset programs – license in for China or global rights
    • Global Rights: open to all stages of preclinical and/or early clinical projects
    • China Rights: programs that have PoC in clinic
  • Consider JV for technology platforms

OUR BUSINESS MODEL

(for newco)

target-icon-LG-wht

DEAL SOURCE

  • Novel discovery/IP from top academic institutions
  • Founding team with technology looking for early funding
  • Platform company looking to expand via newco creation
grow-icon-LG-wht

FUTURE OPTIONS

  • Additional finance from Fosun and/or others​
  • Expansion to China with Fosun Pharma’s help​
  • Global or regional corporate partnership

ADVANTAGES
Access to Fosun Pharma Resources:

Business & Operations
Wide Range R&D Resources & Expertise
Shared Facility & Office Space

Primary Areas of Investment

Therapeutic Areas Examples

  • CNS
  • Autoimmune disease
  • Respiratory disease
  • Metabolic disease
  • Infectious disease
  • Cancer (esp. lung, stomach, liver, esophagus）
  • Rare disease

Technologies Examples

  • Gene therapy
  • Nucleic acids/RNA therapeutics
  • Microbiome
  • Cell therapy
  • ProTAC
  • Vaccines
  • Small & large molecules

What FUSION Offers

FUNDING

  • Enhanced seed”/series-A funding for newco

EXPERIENCE

  • Broad and extensive R&D experience in discovery, preclinical and clinical development
  • Experience in large pharma and start-up companies in US
  • Interim executive leadership where needed

RESOURCES

  • Business functions (BD, legal/IP, finance, HR) shared with Fosun Pharma USA
  • Shared facility & office space
  • Operational and program management
  • Scientific committee / Network of KOLs

ACCESS TO A WIDE RANGE OF RESOURCES THROUGH FOSUN PHARMA

  • Partnership with Fosun Pharma portfolio company technology platforms (small molecules, mAb, CAR-T, stem cells, etc.)
  • Clinical development, regulatory and registration team
  • Manufacturing network (incl. large and small molecules, cell therapy, etc.)
  • Integrated healthcare system including diagnostics, medical device, hospital and clinic network
  • Distribution capabilities and market depth (largest private stake holder of Sinopharm Group) in China

Interested?

Investment/Partnership Submission Form

Contact Us

Fosun Pharma USA reversed logo

104 Carnegie Center Drive, Suite 204,
Princeton, NJ 08540

(609) 250-2875
info.usa@fosunpharma.com 

Contact Customer Service Support at:

Toll-Free (833) 291-9645

Email: GMB-SPS-Fosun@cordlogistics.com
To report an Adverse Event or a Quality complaint, please contact us at:

(866) 611-3762

© 2022 Fosun Pharma USA Inc. All rights reserved.

Let's get started.

Please complete and submit the contact form below.
Be sure to attach any relevant documents for review and consideration.